Immix Biopharma, Inc. Common Stock (IMMX) is a publicly traded Healthcare sector company. As of November 4, 2026, IMMX trades at $7.97 with a market cap of $601.88M and a P/E ratio of -10.68. IMMX moved +0.00% today. Year to date, IMMX is +42.15%; over the trailing twelve months it is +112.06%. Its 52-week range spans $1.34 to $15.10. Analyst consensus is strong buy with an average price target of $25.33. Rallies surfaces IMMX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for IMMX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $7.97 |
| Market Cap | $601.88M |
| P/E Ratio | -10.68 |
| EPS | $-0.89 |
| Dividend Yield | 0.00% |
| 52-Week High | $15.10 |
| 52-Week Low | $1.34 |
| Volume | 15.41K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-29.44M |
| Gross Margin | 0.00% |
6 analysts cover IMMX: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $25.33.